AGS-16M18

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGS-16M18, covering 2013-02-27 to 2013-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer [Phase 1]

See pricing